DXJG:LSE:LSE-WisdomTree Japan Equity UCITS ETF - JPY Acc (GBX)

ETF | Others |

Last Closing

USD 2174.5

Change

-23.25 (-1.06)%

Market Cap

N/A

Volume

267.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+2.75 (+1.49%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.71 (-1.45%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.16 (-0.90%)

USD 557.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.17 (-1.21%)

USD 496.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.20 (-0.28%)

USD 266.08B
0QZO:LSE 0QZO

+0.85 (+0.92%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.30 (+0.78%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.30 (-0.96%)

USD 200.01B
0R24:LSE Intel Corp.

-0.95 (-4.31%)

USD 196.14B

ETFs Containing DXJG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.03% 59% D- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.03% 57% F 58% F
Trailing 12 Months  
Capital Gain 5.12% 33% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.12% 30% F 41% F
Trailing 5 Years  
Capital Gain 44.58% 66% D+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.58% 64% D 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.47% 68% D+ 71% C-
Dividend Return 10.47% 68% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.20% 65% D 79% B-
Risk Adjusted Return 102.66% 96% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike